Chikungunya is one such emerging threat which can continue to have deadly implications even after three months of recovery from the infection, as per a new research published in The Lancet ...

City hospitals are witnessing rare cases of post-dengue, chikungunya mucormycosis, a severe fungal infection commonly known as black fungus, with experts attributing the alarming trend to the ...

The most common symptoms of chikungunya viral infection are fever and joint pain ... 24 hours and seven days after the mosquitoes bit the mice. They determined the levels of cytokines, as well as the ...

Maharashtra witnessed a significant rise in chikungunya cases this year, with 5,757 infections. Patients are experiencing prolonged after-effects like joint pain, fatigue, and neurological ...

A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue fever. Laboratory diagnosis is therefore ...

Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP ... in class to prevent chikungunya infections in adolescents to elderly ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...